Real-World Use of Sotrovimab for Pre-Emptive Treatment in High-Risk Hospitalized COVID-19 Patients: An Observational Cross-Sectional Study

Data on use of monoclonal antibodies (mAbs) in hospitalized patients are limited. In this cross-sectional study, we evaluated the use of mAbs for early treatment of unvaccinated hospitalized patients with mild-to-moderate COVID-19. All inpatients at our center were screened on 27 October 2021. Prima...

Full description

Bibliographic Details

Published in:	Antibiotics
Main Authors:	Sean W. X. Ong, Dongdong Ren, Pei Hua Lee, Stephanie Sutjipto, Christopher Dugan, Bo Yan Khoo, Jun Xin Tay, Shawn Vasoo, Barnaby E. Young, David C. Lye
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Subjects:	COVID-19 SARS-CoV-2 sotrovimab treatment monoclonal antibody
Online Access:	https://www.mdpi.com/2079-6382/11/3/345